Red-emissive carbon dots-based composite nanoparticles for photothermal-enhanced synergistic cancer therapy
摘要
Cancer severely endangers human health, and traditional single-therapy approaches have limitations. This study developed a hyaluronic acid (HA)-targeted self-assembled nanodrug system (DOX/CGFH) for delivering doxorubicin hydrochloride (DOX). The red-emissive carbon dots (R-CDs) exhibited both glutathione oxidase-like activity and photothermal/imaging capabilities, enabling glutathione (GSH) depletion in the tumor microenvironment. GF nanoparticles, synthesized at an optimal ratio, demonstrate high Fenton catalytic activity and near-infrared (NIR) light irradiation, and NIR irradiation significantly enhance the generation of ·OH. This system displayed outstanding photothermal performance (29.7% conversion efficiency) and controllable ·OH production, offering a novel multimodal synergistic strategy for cancer treatment. The DOX/CGFH nanoparticles have a diameter of 40 nm. They displayed multi-stimuli-responsive drug release under pH, GSH, HAase, and NIR light irradiation. DOX/CGFH selectively targeted 4T1 tumor cells via CD44 receptor-mediated internalization. Under NIR light irradiation, DOX/CGFH induced significant photothermal therapy (PTT) and synergized with Fe2+-mediated chemodynamic therapy (CDT) and chemotherapy with a combination index of 0.77, confirming a synergistic effect. The system could trigger apoptosis by reducing mitochondrial membrane potential. Additionally, a tumor spheroid assay demonstrated the potent combined killing effect of DOX/CGFH and NIR. This study provides a new strategy for designing multimodal antitumor nanodelivery systems.
Graphical Abstract